DeLorean (ASX:DEL) has secured $7 million in debt funding to upgrade and expand the SA1 bioenergy plant, which will produce renewable gas, renewable liquid carbon dioxide, and liquid fertiliser.
The funding complements the previously announced $6.1 million from ARENA and the initial debt secured for the baseline-scoped plant in August 2024.
With the additional debt, the SA1 upgraded facility is now fully funded, enabling six monetisation streams and enhancing the plant’s economics.
The project expansion includes infrastructure for renewable natural gas (biomethane), food-grade LCO2, and liquid fertiliser, with a particular focus on the biogenic LCO2 infrastructure to support a 10-year offtake agreement with Supagas.
This deal is expected to boost net profitability by $15-25 million over its term. The SA1 facility’s construction is projected to cost $36 million.
The debt is provided by Delorean's existing partner, Tanarra, as part of a new "Facility C," in addition to the previously announced Facility A and B.
Delorean's Managing Director, Joe Oliver, emphasised that the plant’s expansion positions the company to generate long-term revenue from six clean, sustainable product streams.